Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;6(1):66-70.
doi: 10.1007/s11420-009-9145-4. Epub 2009 Dec 5.

Nonanemic patients do not benefit from autologous blood donation before total hip replacement

Friedrich Boettner, Eric I Altneu, Brendan A Williams, Matthew Hepinstall, Thomas P Sculco

Nonanemic patients do not benefit from autologous blood donation before total hip replacement

Friedrich Boettner et al. HSS J. 2010 Feb.

Abstract

To avoid the potential risks of allogeneic transfusion during total hip arthroplasty (THA), the use of preoperative autologous blood donation (PABD) has been utilized. We performed a retrospective chart review of 283 patients undergoing THA that either donated 1 U of autologous blood (188 patients) or did not donate autologous blood before surgery (95 patients) in order to investigate the difference in postoperative transfusion rate (autologous and allogeneic), the incidence of allogeneic transfusion, and the difference in cost of each protocol. In addition, the study compared transfusion rates in patients with and without preoperative anemia (hemoglobin (Hb) ≤ 12.5 g/dL). At 0.75 transfusions per patient versus 0.22 transfusions per patient, the PABD patients had a significantly higher overall transfusion rate. PABD significantly reduced the need for allogeneic blood in anemic patients (Hb ≤ 12.5 g/dL) from 52.6% to 11.8%. PABD did not have the same affect in nonanemic patients (allogeneic transfusion rate 5.7% versus 4.0%). The study demonstrated that nonanemic patients undergoing THA do not benefit from PABD, but it is effective for anemic patients.

PubMed Disclaimer

References

    1. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J. Bone Jt. Surg. Am. 1999;81(1):2–10. - PubMed
    1. Biesma DH, Marx JJ, Wiel A. Collection of autologous blood before elective hip replacement. A comparison of the results with the collection of two and four units. J. Bone Jt. Surg. Am. 1994;76(10):1471–1475. - PubMed
    1. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J. Bone Jt. Surg. Am. 2002;84-A(8):1299–1304. - PubMed
    1. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J. Arthroplast. 2004;19(3):281–287. doi: 10.1016/j.arth.2003.10.013. - DOI - PubMed
    1. Couvret C, Laffon M, Baud A, Payen V, Burdin P, Fusciardi J. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty. Anesth. Analg. 2004;99(1):262–271. doi: 10.1213/01.ANE.0000118165.70750.78. - DOI - PubMed